RE: ASPET Makes Accepted Manuscripts Freely Accessible

["Rich Dodenhoff" <rdodenhoff@aspet.org>]

Older "Fast Forward" articles will become freely accessible after 12
months, as in the past.  Immediate free access begins for those articles
in our system as of April 28th.

Richard Dodenhoff
Journals Director
American Society for Pharmacology and
  Experimental Therapeutics
9650 Rockville Pike
Bethesda, MD 20814-3995
301.634.7997 (p) / 301.634.7061 (f)

-----Original Message-----
From: owner-liblicense-l@lists.yale.edu [mailto:owner-liblicense-l@lists.yale.edu] On Behalf Of RAPPAZ Francois
Sent: Saturday, April 30, 2005 6:48 AM
To: liblicense-l@lists.yale.edu
Subject: RE: ASPET Makes Accepted Manuscripts Freely Accessible

And what about the fast forward articles that have been published in the
past issues of these journals, will they be also freely accessible ? I
tried a few tests but was unable to get the full text.

Fran�ois Rappaz

Centre de documentation de la Facult� des Sciences Universit� de Fribourg DokPe - Dokumentationszentrum der Naturwissenschaftlichen Fakult�t Universit�t Freiburg P�rolles CH-1700 Fribourg Switzerland http://www.unifr.ch/dokpe/
Tel.: 41 (0)26 300 92 60
Fax.: 41 (0)26 300 97 30

> -----Original Message-----
> [mailto:owner-liblicense-l@lists.yale.edu] On Behalf Of Rich Dodenhoff
> Sent: vendredi, 29. avril 2005 00:32
> To: liblicense-l@lists.yale.edu
> Subject: ASPET Makes Accepted Manuscripts Freely Accessible
> 
> Effective April 28, 2005, manuscripts accepted for publication in the
> primary-research journals of The American Society for Pharmacology and
> Experimental Therapeutics will be freely accessible to all.  The Journal
> of Pharmacology and Experimental Therapeutics, Molecular Pharmacology,
> and Drug Metabolism and Disposition publish manuscripts online upon
> acceptance as "Fast Forward" articles:
> 
> http://jpet.aspetjournals.org/
> http://molpharm.aspetjournals.org/
> http://dmd.aspetjournals.org/
> 
> For all current and future "Fast Forward" articles, the final manuscript
> version will remain freely accessible after the fully formatted and
> copyedited version is put online.  ASPET will continue to make all of
> its journals' content freely available 12 months after publication.
> 
> ASPET's Board of Publications Trustees has also modified each of the
> journal's Authorship Responsibility, Financial Disclosure, and Copyright
> Transfer form to let NIH-funded authors deposit their accepted
> manuscripts with PubMed Central and to make them freely accessible there
> after 12 months.  ASPET asks NIH-funded authors to abide by this embargo
> period for the PubMed Central site because the articles will be freely
> accessible immediately via the journals.  All "Fast Forward" articles
> are indexed in PubMed and other indexing services, so they are easily
> found.
> 
> The changes implemented by ASPET meet the NIH's goals of providing
> greater public access to research and of allowing the NIH to better
> track the results of its funding.  At the same time, the changes will
> contribute to the continued viability of ASPET and its journals while
> providing free access to all research articles published in ASPET's
> journals.
> 
> Rich Dodenhoff, Journals Director
> American Society for Pharmacology and
>   Experimental Therapeutics